• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病相关的肝硬化通常未被识别,且与肝细胞癌有关。

Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma.

作者信息

Bertot Luis C, Jeffrey Gary P, Wallace Michael, MacQuillan Gerry, Garas George, Ching Helena L, Adams Leon A

机构信息

School of Medicine and Pharmacology University of Western Australia Nedlands Western Australia Australia.

Department of Hepatology Sir Charles Gairdner Hospital Nedlands Western Australia Australia.

出版信息

Hepatol Commun. 2017 Feb 27;1(1):53-60. doi: 10.1002/hep4.1018. eCollection 2017 Feb.

DOI:10.1002/hep4.1018
PMID:29404433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5747027/
Abstract

Determination of cirrhosis in nonalcoholic fatty liver disease (NAFLD) is important as it alters prognosis and management. We aimed to examine whether cirrhosis was diagnosed incidentally or intentionally in patients with NAFLD. We reviewed 100 patients with NAFLD cirrhosis to determine mode of cirrhosis diagnosis (incidental or by intent), severity of liver disease at diagnosis, diagnostician, and previous clinical imaging or laboratory evidence of unrecognized cirrhosis. The majority (66/100) of patients with NAFLD cirrhosis were diagnosed incidentally, with the majority of these (74%) diagnosed with NAFLD simultaneously. Those with incidental cirrhosis diagnoses had more deranged platelet and international normalized ratio levels ( < 0.05) and were more likely to have concomitant hepatocellular carcinoma (HCC) (12% versus 0%,  < 0.05). Incidental cirrhosis was diagnosed following imaging (32%) or liver tests (26%) performed for reasons unrelated to liver disease, following unexpected endoscopic finding of varices (21%) or an unexpected surgical finding (14%). Diagnoses by intent were predominantly made by gastroenterologists/hepatologists, whereas general practitioners, surgeons, and physicians tended to diagnose cirrhosis incidentally ( < 0.001). The majority of patients diagnosed incidentally (n = 48/66, 73%) had previous thrombocytopenia, splenomegaly, or high noninvasive fibrosis scores. Following diagnosis, patients diagnosed incidentally were less likely to undergo HCC screening. : The majority of patients with NAFLD cirrhosis are diagnosed incidentally. These patients are more likely to have advanced liver disease and HCC. Increased awareness of screening for cirrhosis is needed in patients with NAFLD. (Hepatology Communications 2017;1:53-60).

摘要

非酒精性脂肪性肝病(NAFLD)中肝硬化的判定很重要,因为它会改变预后和治疗方案。我们旨在研究NAFLD患者的肝硬化是偶然诊断还是有意诊断的。我们回顾了100例NAFLD肝硬化患者,以确定肝硬化的诊断方式(偶然或有意)、诊断时的肝病严重程度、诊断医生以及既往未被识别的肝硬化的临床影像或实验室证据。大多数(66/100)NAFLD肝硬化患者是偶然诊断的,其中大多数(74%)同时被诊断为NAFLD。那些偶然诊断为肝硬化的患者血小板和国际标准化比值水平更紊乱(P<0.05),并且更有可能合并肝细胞癌(HCC)(12%对0%,P<0.05)。偶然肝硬化是在因与肝病无关的原因进行影像检查(32%)或肝功能检查(26%)后、意外内镜发现静脉曲张(21%)或意外手术发现(14%)后诊断的。有意诊断主要由胃肠病学家/肝病学家做出,而全科医生、外科医生和内科医生倾向于偶然诊断肝硬化(P<0.001)。大多数偶然诊断的患者(n = 48/66,73%)既往有血小板减少、脾肿大或高非侵入性纤维化评分。诊断后,偶然诊断的患者接受HCC筛查的可能性较小。结论:大多数NAFLD肝硬化患者是偶然诊断的。这些患者更有可能患有晚期肝病和HCC。NAFLD患者需要提高对肝硬化筛查的认识。(《肝病通讯》2017年;1:53 - 60)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/541d854cef5c/HEP4-1-53-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/0000fdd4a4ba/HEP4-1-53-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/04e84646abdf/HEP4-1-53-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/7118da29c056/HEP4-1-53-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/541d854cef5c/HEP4-1-53-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/0000fdd4a4ba/HEP4-1-53-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/04e84646abdf/HEP4-1-53-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/7118da29c056/HEP4-1-53-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d634/5747027/541d854cef5c/HEP4-1-53-g004.jpg

相似文献

1
Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma.非酒精性脂肪性肝病相关的肝硬化通常未被识别,且与肝细胞癌有关。
Hepatol Commun. 2017 Feb 27;1(1):53-60. doi: 10.1002/hep4.1018. eCollection 2017 Feb.
2
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.非肝硬化非酒精性脂肪性肝病(NAFLD)患者肝细胞癌(HCC)的特征
Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11.
3
Work-up for Incidentally Detected NAFLD: How Far is It Worth?偶然发现的非酒精性脂肪性肝病的检查评估:其价值几何?
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S26-S36. doi: 10.5005/jp-journals-10018-1364.
4
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.非肝硬化非酒精性脂肪性肝病和代谢综合征背景下的肝细胞癌:美国的经验
Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7.
5
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.纤维化严重程度是晚期非酒精性脂肪性肝病患者死因特异性死亡率的决定因素:一项多国队列研究。
Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5.
6
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.非酒精性脂肪性肝病患者中无晚期纤维化的肝细胞癌的临床特征。
J Gastroenterol Hepatol. 2019 Sep;34(9):1626-1632. doi: 10.1111/jgh.14608. Epub 2019 Mar 6.
7
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.美国退伍军人中无肝硬化的肝细胞癌与非酒精性脂肪性肝病相关。
Clin Gastroenterol Hepatol. 2016 Jan;14(1):124-31.e1. doi: 10.1016/j.cgh.2015.07.019. Epub 2015 Jul 18.
8
Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.非酒精性脂肪性肝病:诊断进展
Gene Expr. 2019 Nov 4;19(3):187-198. doi: 10.3727/105221619X15553433838609. Epub 2019 Apr 22.
9
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
10
A Rare Type of Hepatocellular Carcinoma Presenting With Cardiac Thrombus.一种表现为心脏血栓的罕见类型肝细胞癌。
Cureus. 2023 May 28;15(5):e39611. doi: 10.7759/cureus.39611. eCollection 2023 May.

引用本文的文献

1
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary.基层医疗中代谢功能障碍相关脂肪性肝病的评估:共识声明摘要
Med J Aust. 2025 Sep 1;223(5):268-276. doi: 10.5694/mja2.70008. Epub 2025 Jul 28.
2
Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease.淋巴结脂肪过多与代谢功能障碍相关脂肪性肝病
Biomedicines. 2025 Jan 1;13(1):80. doi: 10.3390/biomedicines13010080.
3
NAFLD No More: A Review of Current Guidelines in the Diagnosis and Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

本文引用的文献

1
Screening for liver fibrosis in the general population: a call for action.在普通人群中筛查肝纤维化:行动呼吁。
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):256-260. doi: 10.1016/S2468-1253(16)30081-4. Epub 2016 Oct 12.
2
High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients.2型糖尿病患者中未诊断出的肝硬化和晚期肝纤维化患病率高。
Ann Hepatol. 2016 Sep-Oct;15(5):721-8. doi: 10.5604/16652681.1212434.
3
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
非酒精性脂肪性肝病不再:代谢相关脂肪性肝病(MASLD)的诊断和评估中当前指南的综述。
Curr Diab Rep. 2024 Nov 13;25(1):5. doi: 10.1007/s11892-024-01558-y.
4
Health disparities in cirrhosis care and liver transplantation.肝硬化护理与肝移植中的健康差异。
Nat Rev Gastroenterol Hepatol. 2025 Feb;22(2):98-111. doi: 10.1038/s41575-024-01003-1. Epub 2024 Oct 31.
5
An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations.澳大利亚2型糖尿病患者基于社区的代谢功能障碍相关脂肪性肝病护理路径:障碍与考量
Patient Prefer Adherence. 2024 Sep 9;18:1845-1855. doi: 10.2147/PPA.S468705. eCollection 2024.
6
Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis.慢性肝病的早期筛查:FIB-4 首次综合护理路径对识别有显著纤维化患者的影响。
Sci Rep. 2024 Sep 5;14(1):20720. doi: 10.1038/s41598-024-66210-x.
7
Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.利用退伍军人事务部电子健康记录中的弹性成像数据检测肝脂肪变性的预测算法。
Dig Dis Sci. 2023 Dec;68(12):4474-4484. doi: 10.1007/s10620-023-08043-8. Epub 2023 Oct 21.
8
Development and validation of a nomogram for predicting metabolic-associated fatty liver disease in the Chinese physical examination population.开发和验证适用于中国体检人群的预测代谢相关脂肪性肝病的列线图。
Lipids Health Dis. 2023 Jun 29;22(1):85. doi: 10.1186/s12944-023-01850-y.
9
A salivary biomarker panel to detect liver cirrhosis.一种用于检测肝硬化的唾液生物标志物组合。
iScience. 2023 Jun 5;26(7):107015. doi: 10.1016/j.isci.2023.107015. eCollection 2023 Jul 21.
10
Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.益生菌、益生元和合生元在非酒精性脂肪性肝病和酒精相关性肝病中的作用。
Am J Physiol Gastrointest Liver Physiol. 2023 Jul 1;325(1):G42-G61. doi: 10.1152/ajpgi.00017.2023. Epub 2023 May 2.
欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
4
Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.门静脉高压并发症常常是接受肝移植评估患者非酒精性脂肪性肝病的首发表现。
Dig Dis Sci. 2016 Jul;61(7):2102-7. doi: 10.1007/s10620-016-4124-3. Epub 2016 Mar 18.
5
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
6
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病:系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
7
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.欧洲肝脏研究学会-阿莱赫临床实践指南:用于评估肝脏疾病严重程度和预后的非侵入性检查
J Hepatol. 2015 Jul;63(1):237-64. doi: 10.1016/j.jhep.2015.04.006. Epub 2015 Apr 21.
8
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.应用受控衰减参数和肝硬度测量筛查糖尿病患者的非酒精性脂肪性肝病:一项前瞻性队列研究。
Gut. 2016 Aug;65(8):1359-68. doi: 10.1136/gutjnl-2015-309265. Epub 2015 Apr 14.
9
Gaps in recognition and evaluation of incidentally identified hepatic steatosis.偶然发现的肝脂肪变性的识别和评估方面存在差距。
Dig Dis Sci. 2015 Feb;60(2):333-8. doi: 10.1007/s10620-014-3346-5. Epub 2014 Sep 5.
10
Nonalcoholic fatty liver disease is underrecognized in the primary care setting.非酒精性脂肪性肝病在初级保健环境中未得到充分认识。
Am J Gastroenterol. 2015 Jan;110(1):10-4. doi: 10.1038/ajg.2014.134. Epub 2014 Jun 3.